eXmoor Pharma

Who are we?
eXmoor Pharma is a specialist cell and gene therapy CDMO with embedded consultancy expertise. Since 2004, the team has supported viral vectors, autologous and allogeneic cell therapies, and RNA technologies, guiding projects from early CMC strategy through GMP manufacture. Clients benefit from regulatory insight, freedom to operate on IP, and a collaborative model that helps accelerate milestones.

What we are showcasing at ATW 2026
Available GMP manufacturing capacity at our UK facility licensed by the MHRA, enabling scale-up and clinical trial expansion into Europe. The facility has been operational since 2023 under MIA(IMP) license number 32954.

Solutions and services

• CMC consulting, including CMC strategy, cost of goods, GMP compliance and QP services, investor and technical due diligence, and interim leadership

• Process and analytical development for vectors, cells, and RNA

• GMP clinical manufacturing with quality and regulatory support

• Fill finish for investigational products

• Cell banking

• Facility design and process engineering

Proven track record

• 627 projects delivered for 188 clients since 2004

• 20+ years of CMC expertise across viral vector, cell therapy, and RNA modalities